Table 3.

Median TNT (95% CI) in months for the most frequently received chemotherapy agents in 3L or greater compared with all other single agents received in 3L or greater

Chemotherapy agents	3L and greater regimen (left‐hand column)	All other 3L and greater single‐agent chemotherapya
	TNT (95% CI)	TNT (95% CI)	p valueb
Capecitabine	6.2 (5.6–7.1)	4.4 (3.9–4.8)	.041
Eribulin	3.9 (3.3–4.6)	4.8 (3.1–5.7)	.110
Nab‐paclitaxel	6.2 (4.8–7.4)	4.4 (3.9–4.9)	.049
Gemcitabine	3.6 (2.8–4.8)	4.8 (4.3–5.3)	.144
Liposomal doxorubicin	3.9 (3.4–6.2)	4.6 (4.1–5.2)	.898

^aMedian for all other single agents does not include the comparison regimen listed in the left‐hand column.

^b p‐value compares most common regimen median TNT to the median TNT of all other single agents used in 3L or greater by log‐rank test.

Abbreviations: CI, confidence interval; 3L, third‐line; TNT, time to next treatment.